136 related articles for article (PubMed ID: 22280365)
1. The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.
Al Sorkhy M; Ferraiuolo RM; Jalili E; Malysa A; Fratiloiu AR; Sloane BF; Porter LA
BMC Cancer; 2012 Jan; 12():45. PubMed ID: 22280365
[TBL] [Abstract][Full Text] [Related]
2. The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.
Fifield BA; Qemo I; Kirou E; Cardiff RD; Porter LA
Breast Cancer Res; 2019 Dec; 21(1):140. PubMed ID: 31829284
[TBL] [Abstract][Full Text] [Related]
3. The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.
Golipour A; Myers D; Seagroves T; Murphy D; Evan GI; Donoghue DJ; Moorehead RA; Porter LA
Cancer Res; 2008 May; 68(10):3591-600. PubMed ID: 18483240
[TBL] [Abstract][Full Text] [Related]
4. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor.
Liu P; Kao TP; Huang H
Oncogene; 2008 Aug; 27(34):4733-44. PubMed ID: 18408765
[TBL] [Abstract][Full Text] [Related]
5. Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.
Al Sorkhy M; Fifield BA; Myers D; Porter LA
Cell Cycle; 2016; 15(1):128-36. PubMed ID: 26771716
[TBL] [Abstract][Full Text] [Related]
6. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
Porter LA; Dellinger RW; Tynan JA; Barnes EA; Kong M; Lenormand JL; Donoghue DJ
J Cell Biol; 2002 Apr; 157(3):357-66. PubMed ID: 11980914
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments.
Ferraiuolo RM; Fifield BA; Hamm C; Porter LA
Breast Cancer Res Treat; 2022 Nov; 196(1):17-30. PubMed ID: 36029387
[TBL] [Abstract][Full Text] [Related]
8. The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis.
McAndrew CW; Gastwirt RF; Donoghue DJ
Cell Cycle; 2009 Jan; 8(1):66-75. PubMed ID: 19106603
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Zeng Z; Lin H; Zhao X; Liu G; Wang X; Xu R; Chen K; Li J; Song L
Clin Cancer Res; 2012 Aug; 18(15):4059-69. PubMed ID: 22675169
[TBL] [Abstract][Full Text] [Related]
10. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation.
Fifield BA; Talia J; Stoyanovich C; Elliott MJ; Bakht MK; Basilious A; Samsoondar JP; Curtis M; Stringer KF; Porter LA
Carcinogenesis; 2020 Jul; 41(6):850-862. PubMed ID: 31574533
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression.
Zhang Q; Sakamoto K; Liu C; Triplett AA; Lin WC; Rui H; Wagner KU
Cancer Res; 2011 Dec; 71(24):7513-24. PubMed ID: 22037875
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
16. CXCL1 Derived from Mammary Fibroblasts Promotes Progression of Mammary Lesions to Invasive Carcinoma through CXCR2 Dependent Mechanisms.
Bernard S; Myers M; Fang WB; Zinda B; Smart C; Lambert D; Zou A; Fan F; Cheng N
J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):249-267. PubMed ID: 30094610
[TBL] [Abstract][Full Text] [Related]
17. Spy1 is frequently overexpressed in malignant gliomas and critically regulates the proliferation of glioma cells.
Zhang L; Shen A; Ke Q; Zhao W; Yan M; Cheng C
J Mol Neurosci; 2012 Jul; 47(3):485-94. PubMed ID: 22447439
[TBL] [Abstract][Full Text] [Related]
18. Oxalate induces breast cancer.
Castellaro AM; Tonda A; Cejas HH; Ferreyra H; Caputto BL; Pucci OA; Gil GA
BMC Cancer; 2015 Oct; 15():761. PubMed ID: 26493452
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
Salah Z; Itzhaki E; Aqeilan RI
Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
[TBL] [Abstract][Full Text] [Related]
20. Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice.
Ray D; Terao Y; Nimbalkar D; Hirai H; Osmundson EC; Zou X; Franks R; Christov K; Kiyokawa H
Cancer Res; 2007 Jul; 67(14):6605-11. PubMed ID: 17638870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
